Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.
Author: Sarah Collins
Teva stock has gained ~27.0% year-to-date on the back of the positive news that included product launches and study data.
Today, CVS Health, the leading pharmacy benefit managers, is up ~5% after announcing the launch of its drug delivery service from all of its US locations.
On February 20, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy to develop its robot-assisted orthopedics surgery platform.
In 4Q17, the momentum in Stryker's (SYK) Mako robot installations continued with total worldwide installations of 35 Mako robots.
Johnson & Johnson (JNJ) announced its fiscal 4Q17 and fiscal 2017 earnings results on January 23, 2018.
On December 28, 2017, Align Technology (ALGN) was the top-performing stock in the S&P 500. ALGN has generated an ~130.0% return during the past year.
On December 20, 12 of 24 analysts surveyed by Reuters rated Medtronic (MDT) stock as a "buy," and the remaining 12 analysts recommended a "hold." There were no "sell" ratings given to MDT stock.
Medtronic (MDT) is consistently working on expanding access to and improving diabetes management via new and enhanced products and services.